E-LIB Suche - Ergebnisse für: Mohty, B.

1

Azacitidine–venetoclax versus azacitidine salvage treatment..:

Petit, C. ; Saillard, C. ; Mohty, B....
European Journal of Haematology. 112 (2023) 4 - p. 530-537 , 2023

Link: https://doi.org/10.1111/..

2

P534: AZACITIDINE PLUS VENETOCLAX FOR THE TREATMENT OF RELA..:

Garciaz, S. ; Hospital, M.-A. ; Alary, A.-S....
HemaSphere. 6 (2022) - p. 433-434 , 2022

Link: https://doi.org/10.1097/..

3

Post-remission therapy of adults aged 60 and older with acu..:

Bouchacourt, B. ; Hospital, M. A. ; Zemmour, C....
Annals of Hematology. 99 (2020) 4 - p. 773-780 , 2020

Link: https://doi.org/10.1007/..

4

A chemogenomic approach to identify personalized therapy fo..:

Collignon, A. ; Hospital, M. A. ; Montersino, C....
Blood Cancer Journal. 10 (2020) 6 - p. , 2020

Link: https://doi.org/10.1038/..

5

The patient's CMV serological status affects clinical outco..:

Crocchiolo, R ; Castagna, L ; Furst, S...
Bone Marrow Transplantation. 51 (2016) 8 - p. 1134-1136 , 2016

Link: https://doi.org/10.1038/..

6

The calcineurin inhibitor and the intensity of the conditio..:

Rimondo, A ; Crocchiolo, R ; El-Cheikh, J...
Bone Marrow Transplantation. 52 (2016) 1 - p. 135-137 , 2016

Link: https://doi.org/10.1038/..

7

Erratum: Tacrolimus compared with cyclosporine A after hapl..:

Castagna, L ; Bramanti, S ; Furst, S...
Bone Marrow Transplantation. 51 (2016) 3 - p. 470-470 , 2016

Link: https://doi.org/10.1038/..

8

128 SINGLE CENTER EXPERIENCE OF RIC BASED ALLOGENIC HEMATOP..:

Blaise, D. ; Saillard, C. ; Fürst, S....
Leukemia Research. 39 (2015) - p. S66 , 2015

Link: https://doi.org/10.1016/..

9

European guidelines for prevention and management of influe..:

Engelhard, D. ; Mohty, B. ; de la Camara, R...
Transplant Infectious Disease. 15 (2013) 3 - p. 219-232 , 2013

Link: https://doi.org/10.1111/..

10

A chemogenomic approach to identify personalized therapy fo..:

Collignon, A ; Hospital, M., A ; Montersino, C...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41408-020-0330-5. , 2020

Link: https://inserm.hal.scien..

11

A chemogenomic approach to identify personalized therapy fo..:

Collignon, A ; Hospital, M., A ; Montersino, C...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41408-020-0330-5. , 2020

Link: https://inserm.hal.scien..

12

A chemogenomic approach to identify personalized therapy fo..:

Collignon, A ; Hospital, M ; Montersino, C...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41408-020-0330-5. , 2020

Link: https://www.hal.inserm.f..

13

P534: AZACITIDINE PLUS VENETOCLAX FOR THE TREATMENT OF RELA..:

S. Garciaz ; M.-A. Hospital ; A.-S. Alary...
http://journals.lww.com/10.1097/01.HS9.0000845024.01860.8d. , 2022

Link: https://doi.org/10.1097/..

14

Tandem autologous-allogeneic stem cell transplantation as a..:

R. Crocchiolo ; L. Castagna ; S. Garciaz...
info:eu-repo/semantics/altIdentifier/pmid/26206800. , 2015

Link: http://hdl.handle.net/24..

15

French early nationwide idecabtagene vicleucel chimeric ant..:

Ferment, B. ; Lambert, J. ; Caillot, D....
British Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..